1. Home
  2. AGIO vs XRAY Comparison

AGIO vs XRAY Comparison

Compare AGIO & XRAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • XRAY
  • Stock Information
  • Founded
  • AGIO 2007
  • XRAY 1899
  • Country
  • AGIO United States
  • XRAY United States
  • Employees
  • AGIO N/A
  • XRAY N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • XRAY Medical/Dental Instruments
  • Sector
  • AGIO Health Care
  • XRAY Health Care
  • Exchange
  • AGIO Nasdaq
  • XRAY Nasdaq
  • Market Cap
  • AGIO 2.4B
  • XRAY 2.6B
  • IPO Year
  • AGIO 2013
  • XRAY 1987
  • Fundamental
  • Price
  • AGIO $41.13
  • XRAY $13.17
  • Analyst Decision
  • AGIO Strong Buy
  • XRAY Hold
  • Analyst Count
  • AGIO 4
  • XRAY 12
  • Target Price
  • AGIO $59.33
  • XRAY $18.30
  • AVG Volume (30 Days)
  • AGIO 514.0K
  • XRAY 3.1M
  • Earning Date
  • AGIO 10-30-2025
  • XRAY 11-06-2025
  • Dividend Yield
  • AGIO N/A
  • XRAY 4.98%
  • EPS Growth
  • AGIO N/A
  • XRAY N/A
  • EPS
  • AGIO 11.13
  • XRAY N/A
  • Revenue
  • AGIO $40,875,000.00
  • XRAY $3,671,000,000.00
  • Revenue This Year
  • AGIO $23.74
  • XRAY N/A
  • Revenue Next Year
  • AGIO $159.90
  • XRAY $1.50
  • P/E Ratio
  • AGIO $3.77
  • XRAY N/A
  • Revenue Growth
  • AGIO 30.57
  • XRAY N/A
  • 52 Week Low
  • AGIO $23.42
  • XRAY $11.69
  • 52 Week High
  • AGIO $62.58
  • XRAY $24.86
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 50.11
  • XRAY 53.94
  • Support Level
  • AGIO $41.24
  • XRAY $12.81
  • Resistance Level
  • AGIO $44.25
  • XRAY $13.18
  • Average True Range (ATR)
  • AGIO 1.52
  • XRAY 0.34
  • MACD
  • AGIO -0.16
  • XRAY 0.10
  • Stochastic Oscillator
  • AGIO 31.28
  • XRAY 90.75

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

Share on Social Networks: